MediSearch
About MediSearch
MediSearch is a search engine for medical information that aims to provide direct answers to medical questions. It uses large language models and trustworthy sources to deliver concise, accurate responses. The company participates in Y Combinator's Summer 2023 batch (YC S23), highlighting its progress within a well-known startup accelerator. More information is available on its website at medisearch.io.
Company at a glance
Location
Life at MediSearch
Frequently asked questions
Companies similar to MediSearch
Aira is an AI platform designed for procedural specialties that serves as the payer intelligence layer for medical device companies and surgical practices. The company automates critical back-office workflows while handling the full payer compliance lifecycle, including benefits verification, medical necessity determinations, prior authorization, and appeals management. By functioning as the intelligence layer powering market access teams, Aira helps healthcare providers and device manufacturers navigate the complexity of reimbursement processes to increase patient access to needed procedures. The platform addresses a key pain point in healthcare operations by streamlining the administrative burden that often delays care and complicates market entry for medical innovations.
Aniva is a health optimization company. It positions itself as a preventive health operating system. It markets itself as Europe's most comprehensive blood check-up. Its mission is to simplify the journey to better health, making it accessible and effective for everyone.
The company provides emergency medicine and urgent care staffing software and sells operational systems to staffing groups. It serves 100+ health systems and clinics nationwide and is focused on scaling its software after an MVP. Founded by two cofounders, the company has a small team of seven, with five full-time US citizens on-site and two remote contractors, and its office is based in Miami where in-person work is required. The organization has early pre-seed funding from Leonis Capital and angel investors, and equity is a part of compensation, with the company unable to sponsor visas. More information is available at describemed.com.



